{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:23:46Z","timestamp":1780431826227,"version":"3.54.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbadis.2017.07.027","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T15:17:22Z","timestamp":1501082242000},"page":"1461-1467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"PB","title":["Current controversies in cholangiocarcinoma"],"prefix":"10.1016","volume":"1864","author":[{"given":"Sergio","family":"Hoyos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Claudino","family":"Botero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2017.07.027_bb0005","author":"International Agency for Research on Cancer (IARC)"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0015","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-2-10","article-title":"Worldwide trends in mortality from biliary tract malignancies","volume":"2","author":"Patel","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/1098-2388(200009)19:2<156::AID-SSU8>3.0.CO;2-#","article-title":"Cholangiocarcinoma of the extrahepatic bile ducts","volume":"19","author":"Jarnagin","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/hbsn.2017.01.04","article-title":"Intrahepatic cholangiocarcinoma: from diagnosis to treatment","volume":"6","author":"Pawlik","year":"2017","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0060","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0065","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2011"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma\u2014controversies and challenges","volume":"8","author":"Patel","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0075","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.24227","article-title":"New staging system and a registry for perihilar cholangiocarcinoma","volume":"53","author":"Deoliveira","year":"2011","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0080","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0085","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0090","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ijc.30211","article-title":"International trends in liver cancer incidence, overall and by histologic subtype, 1978\u20132007","volume":"139","author":"Petrick","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0100","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1053\/j.gastro.2004.09.022","article-title":"Issues in screening and surveillance for hepatocellular carcinoma","volume":"127","author":"di Bisceglie","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canep.2015.04.006","article-title":"Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications","volume":"39","author":"Sartorius","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0115","series-title":"World Cancer Report 2008","author":"International Agency for Research on Cancer (IARC)","year":"2008"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0120","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat. Rev. Gastroenterol Hepatology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0130","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ije\/25.5.933","article-title":"Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea","volume":"25","author":"Shin","year":"1996","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0135","first-page":"959","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3748\/wjg.14.632","article-title":"Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China","volume":"14","author":"Zhou","year":"2008","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0145","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0150","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","article-title":"Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma","volume":"95","author":"Yamamoto","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.2910480302","article-title":"Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma","volume":"48","author":"Parkin","year":"1991","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0160","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2005.11.040","article-title":"Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea","volume":"44","author":"Choi","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0165","first-page":"1221","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-12-289","article-title":"Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-015-0583-9","article-title":"Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies","volume":"13","author":"Li","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0180","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1002\/cncr.24471","article-title":"Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases","volume":"115","author":"Wu","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0185","first-page":"737","article-title":"Detection of HCV in bile duct epithelium by laser capture microdissection (LCM)","volume":"19","author":"Fillipowicz","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0190","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1038\/sj.onc.1209558","article-title":"Liver stem cells and their implication in hepatocellular and cholangiocarcinoma","volume":"25","author":"Roskams","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0195","first-page":"1019","article-title":"Neuroendocrine features of reactive bile ductules in cholestatic liver disease","volume":"137","author":"Roskams","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0200","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1099\/vir.0.000090","article-title":"Hepatitis C virus infection of cholangiocarcinoma cell lines","volume":"96","author":"Fletcher","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056272","article-title":"MicroRNA-122 dependent binding of Ago2 protein to hepatitis C virus RNA is associated with enhanced RNA stability and translation stimulation","volume":"8","author":"Conrad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0210","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1046\/j.1365-2168.2002.02211.x","article-title":"Pathological appraisal of lines of resection for bile duct carcinoma","volume":"89","author":"Ebata","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000658-199803000-00013","article-title":"The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases","volume":"227","author":"Sakamoto","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0220","first-page":"625","article-title":"Study of the intrahepatic surgical margin of hilar bile duct carcinoma","volume":"49","author":"Okazaki","year":"2002","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00534-009-0204-5","article-title":"Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience","volume":"17","author":"Lee","year":"2010","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0230","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/000313481207800440","article-title":"The proximal margin of resected hilar cholangiocarcinoma: the effect of microscopic positive margin on long-term survival","volume":"78","author":"Lee","year":"2012","journal-title":"Am. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0235","first-page":"65","article-title":"Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival","volume":"37","author":"van Gulik","year":"2011","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.SLA.0000074984.83031.02","article-title":"Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization","volume":"238","author":"Kawasaki","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0245","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s11605-012-1960-0","article-title":"Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience","volume":"16","author":"Cho","year":"2012","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0250","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.amjsurg.2007.07.033","article-title":"Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience","volume":"196","author":"Konstadoulakis","year":"2008","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0255","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/bjs.6618","article-title":"Extent of liver resection for hilar cholangiocarcinoma","volume":"96","author":"Chen","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0260","first-page":"153","article-title":"Surgical treatment of hilar carcinoma of the bile duct","volume":"162","author":"Mizumoto","year":"1986","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0265","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF01658686","article-title":"Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus","volume":"14","author":"Nimura","year":"1990","journal-title":"World J. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00000658-199301000-00005","article-title":"Improvements in survival by aggressive resections of hilar cholangiocarcinoma","volume":"217","author":"Baer","year":"1993","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0275","first-page":"597","article-title":"Outcome of radical surgery in hilar cholangiocarcinoma","volume":"107","author":"Hadjis","year":"1990","journal-title":"Surgery"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0280","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1477-2574.2012.00616.x","article-title":"Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma","volume":"15","author":"Abbas","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0285","first-page":"489","article-title":"Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"40","author":"Chen","year":"2014","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0290","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s11605-013-2202-9","article-title":"Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies","volume":"17","author":"Wu","year":"2013","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hpb.2015.07.006","article-title":"Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database","volume":"18","author":"Jutric","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0300","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00535-015-1071-2","article-title":"The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics","volume":"50","author":"Morine","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0305","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0310","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0315","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma","volume":"239","author":"Robles","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0325","first-page":"1","article-title":"Assessment of five-year experience with abdominal organ cluster transplantation","volume":"180","author":"Alessiani","year":"1995","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0330","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0002-9610(05)80696-8","article-title":"Is liver transplantation indicated for cholangiocarcinoma?","volume":"166","author":"Goldstein","year":"1993","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0335","first-page":"214","article-title":"A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures","volume":"2","author":"Baron","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0340","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0345","article-title":"Cancer review: cholangiocarcinoma","volume":"14","author":"Ghouri","year":"2015","journal-title":"J. Carcinog."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0350","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.humpath.2007.04.015","article-title":"Fluorescence in situ hybridization in diagnostic cytology","volume":"38","author":"Halling","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0360","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0365","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1200\/JCO.2012.43.3755","article-title":"Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute","volume":"31","author":"Hainsworth","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0370","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1245\/s10434-014-4247-8","article-title":"The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology","volume":"23","author":"Ferrone","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0375","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0380","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0385","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/PAS.0000000000000585","article-title":"BSEP and MDR3: useful immunohistochemical markers to discriminate hepatocellular carcinomas from intrahepatic cholangiocarcinomas and hepatoid carcinomas","volume":"40","author":"Fujikura","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0390","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0395","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MOG.0b013e32830bf7e1","article-title":"Endoscopic tissue diagnosis of cholangiocarcinoma","volume":"24","author":"Harewood","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0405","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Organisation For Research And Treatment Of Cancer, EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0410","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases, management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0415","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0039-6060(99)70203-5","article-title":"Proximal bile duct stricture disguised as malignant neoplasm","volume":"125","author":"Nakayama","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2168.2001.01607.x","article-title":"Incidence of benign lesions in patients resected for suspicious hilar obstruction","volume":"88","author":"Gerhards","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0425","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?","volume":"215","author":"Rosen","year":"2012","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0430","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures","volume":"103","author":"Levy","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0435","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0440","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"ABC-02 Trial Investigators, Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0445","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ctrv.2008.11.009","article-title":"Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions","volume":"35","author":"Anderson","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0450","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semradonc.2014.01.001","article-title":"Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer","volume":"24","author":"Williams","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0455","first-page":"309A","article-title":"Adjuvant therapy for biliary malignancies: international trends and possibilities","volume":"7","author":"Pitt","year":"2003","journal-title":"J. Gastrointest. Surg."},{"issue":"48","key":"10.1016\/j.bbadis.2017.07.027_bb0460","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ejca.2011.11.006","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma","volume":"1990","author":"Borbath","year":"2012","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0465","first-page":"231","article-title":"GICO, cholangiocarcinoma: current opinion on clinical practice diagnostic and therapeutic algorithms: a review of the literature and a long-standing experience of a referral center","volume":"48","author":"Brandi","year":"2016","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0470","doi-asserted-by":"crossref","first-page":"14744","DOI":"10.18632\/oncotarget.4539","article-title":"Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies","volume":"6","author":"Brandi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2017.07.027_bb0475","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ng.3386","article-title":"Building a staircase to precision medicine for biliary tract cancer","volume":"47","author":"Razumilava","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2017.07.027_bb0480","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917302594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917302594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:42:50Z","timestamp":1760416970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917302594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0925443917302594"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.027","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current controversies in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}